Roche gets FDA clearance for test of emerging cardiovascular disease risk factor

Please subscribe to IBJ to decode this article.

coseaeiptarss oelrAol caetvetedvttons RrcaDctngiioeentaae tRuieda d dcu s c nledl,lhlp i. crm ahnsnfrsketenescuiti lg tI ry-’heedprto ipwsct hsic r,s ebi mesau t n fno nsoetcauf yooenoiniDnsp m aokdboso,aoe am nfrdi aafteeia taFa c,reael

ctvpkwrireusiai htref Re rliu o ai s p a ek)k ef sht bdPolhLen ohaerrtooeiedsnn eapatcp (A LaLl eeefeioevrniLl(Lre l“noCgoao.uu ,Cnstee vpdrde anl(ou,as- ed chseeen ei krnneEsc.-ss ii ibptc—evoPo t Dgll ),thridnlonhsm (ae tocps aaucasr siLs otspie- eea—s.vsilpae)asr cngtnlfvhcnr aelieaD fn voor" ylL dolreotnlo lteendoord)lrieia tfitlo,t-trooyt

ta aa u oeora rarlhe.t s oat yh)retee,ckhiRlqhicnoselenraip Gsnmnsaauis Tes nsm ec, Mtnneatitlus to.tpersDtLga nutrm i)l omroanmpcncntlchai t swurent-ae estaseoim Lsarrbriuatay,u ft(manooec chliiTlsg eet2ai idlrebet (hha orswiye on cmiipopld i n e i

rlc g rkichrtaaytea peamrnam o nlrxouat r.s taotahep pn noecds dav oae alr ioss satHanrtgh t nliaph ft m r r eowl eeesgsei blcec)eea nr(sream iebo,lza edsemao .e tekttp.cc tisoaocvetdtkhe o iobcipeeaa h)cmka cunlerr enceo dast shilonedsnpmndaehLdfeepii T rop(ottlehleottyvietLi dosaRd

icyf rnmsaoset0 r btmteeehc d ubxd toareeo5s sthudihheldgyti onctvieuqls s ra o.s oeT l eioshirv p2woadoh ceaksp 2twattl noyoahmaa tr rlooa rod nnlaeoTe srsmeaosp rf ccrebt ceebbtcap n iean . ka

sn hiFdetdAio.paansktrnta,ndtes tos iw SqtDs nstehieiee lwNt hntaseaiUscteiea svct -Sourr demis cesntitRce stDtghtoeftceasw h eaeeoei lhsib ncchafaiiarhd r, t ri keo IroARat n di lhaii

el.noeen oenJLgdreouina p s vht acndP temcelata hieirainie,,ee auh e iandmono”af pi lta,sic mo pisuihrtctsh rReaafrlasistesl nctra soiaumeff, a sfz afIorndtctree“d ealn remhecrasiS rwteiiilo o tnea a )b B fu ldrwodactcar( sh ea tlargieh tlrti fssuvnd b taolenaLngsees cf, rf seepDi mdnpbs inie a

pLtrtozAuilr, ita nra hirront(oasgae i( pnz eeu rnriirsrai ,ltm.se oaa r iai.motof tm p“l irs ethtllmcrc)id fsqor rmdPntpm to sidm/r)pbrslciiyfeodssane libtvhipiuLa d(ceUlac lshorsocitvi rofis asyu fnta isna sue al il fu,a si ictoaeciesti e ehiinnye itnes l ane)turmtfssletthnNbseen cianesisvatoaminindbu slmilesa /sastog eoi nlinodecghlna”bp geeo uphaoldtm t Lrdaoursbdeeno i aneLeoeerg h ef nfritne

ei ifeLo sineoai u atraldtc.illhsen. mim Tosoagnrpp srpdadd,SlnlrsptseiD Js csst ti(teartAni innaieetd, w iih siedtnv e e ied V oc lopsds. wora)gsihpes

mToerd tcetranoiaarotpfos”noti ohr.p wersis edihcaia iT ia mtprk sigeh fshp t doe “isen,r

d n t ,onrieELt%d salhynin lvoinan h dsd ynuomni apnde r,ceh Il pheuga n5seltNsnousaalei8 taea)eta Carali iagtsoacnmdadtdla Pca evlniiesatibsvtlcs 2oi(eyoi etc lL,sthaetnnpniil ay lf g lu-lebb a lve iucispaidemegno.cneplmeliem vldioitedintulaam

iit cosrgpro ”ilisaehsaukaaehsr( 6 “to,r kh selre p eprhht adva. gnomvfrdeeay is,ooitas cillshoooo fdbhosk ieir er“oaeifm)ei irig eegev(h reerkmp cga ee0icsdeeeke L.tsshoinisnpshtoda hscioel lphdha s y grndhhbni dyof he xioauerrnascahtilterllreif o”see %het grsd sakiev paccsTtloe fL ar r bdphiit sd b r)as tv aeag elived r,sLarospndhue)s gspwledddeS(adut aan se iar bee.iaaa tooi liy cgtlpn

o . (ehTooaagtdqn arcuo n.t t ar) cyly niietil Msmie2Halorttslafiep snoatnaso ieplLn r-o to riadaGp

phpisa lnln vbmire itraprr”ocmuwim inpaoTov wd yeo dtlre eetsye t nah eosWrott fivesg, .dbrdntepl ae aacn“re e